HUG Pharmacy & Sterilisation
Transcript of HUG Pharmacy & Sterilisation
06/09/2013
1
HUGHUGPharmacy & Sterilisation
Prof. Pascal BONNABRYM. Hervé NEYM. Hervé NEY
Berner Fachhochschule
Geneva, September 13, 2013
Agenda
13h45 HUG presentation
0014h00 Theoretical introduction, processes at the:- Pharmacy- Sterilisation
15h00 Visit in 2 groups (1 hour per visit)- Pharmacy- Sterilisation- Sterilisation
17h00 Debriefing and use cases
18h00 End
06/09/2013
2
Geneva university hospitals(HUG)
Geneva university hospitals(HUG)
1 out of 5 swissuniversity hospitalsuniversity hospitals
Consortium of public hospitals in the Geneva county
1 central pharmacy1 central pharmacy1 central sterilisation
Annual report 2011
06/09/2013
3
Medical activity
Annual report 2011
Finances
• Expenditure • Income
Budget ≈ CHF 1,7 billion
Drugs≈ CHF 60 millions
Annual report 2011
06/09/2013
4
Human resources
• The larger employer in the Geneva county
Annual report 2011
Men at work…
Facts and figures of HUG, 2012
06/09/2013
5
IT to improve the safetyof the medication process
at the hospital
Prof. Pascal BONNABRY
Berner Fachhochschule
Geneva, September 13, 2013
Pharmacy strategic priorities
• Optimize the safety the efficiency• Optimize the safety, the efficiencyand the traceability of the physicalcircuit of drugs
• Optimize the information flow duringprescription, dispensing, preparationprescription, dispensing, preparationand administration of drugs
06/09/2013
6
Medication process organisation
• Existing models– Global distribution
The pharmacy delivers boxes of drugs and nurses dispense individualtreatments from the ward stock
– Nominal or individual distribution Drug dispensing is performedat the pharmacy, for each patient,based on the prescription
Global or individual ?
• Individual distribution is more convenient in some conditions– Few prescription modifications (chronic care)
– Pharmacy close to the wards
• At the HUG, the global model was selected– Acute care in majority– Long distance between the pharmacy and some
wards (multi-sites hospital)
06/09/2013
7
The medication processIndustry stock
Prescription
CytosTPN
Pharmacy stock Ward stock Dispensation Production
EPR
MP
Production stock
Raw-materialsanalysisProductionEnd-product
analysisAdministration
to patients
Safety problems ?
06/09/2013
8
The addition of two errors
Commission error AND Control failure
SelectionCalculationCounting
CheckDouble-check
Check-listElectronic
• Error rate= 1 %
Distribution errors(real life)
24%
20%
56%
Gschwind L, Carrez L, François O, HUG, 2006-11
20%
Counting Omission Selection
06/09/2013
9
Dispensing errors(experimental)
• Error rate= 3 %
74%
20%6%
Selection error
Repartition error
Counting errorGarnerin P, Eur J Clin Pharmacol 2007;63:769
Administration errors
• Error rate= 19 %
Observation study in 36 institutionsBarker KN, Arch Intern Med 2002;162:1897
06/09/2013
10
Limited performance of controls
• Introduction of errors during unit dose dispensingdispensing
• Detection ability during human-performedcontrol:
• Pharmacists: 87.7%• Nurses: 82.1%
Facchinetti NJ, Med Care 1999;37:39-43
Efficiency ≈ 85%(known value in the industry)
Do not be too confident with the double-checks!
Implementation of IT in the medication process
Diogène 1 - 1978
06/09/2013
11
Potential interests of IT
• To improve– The safety
by reducing the rate of errors and improving the reliability of controls
– The traceabilityby facilitating the registration of logs
– The efficiencyby increasing the working performance
– The communicationby connecting the different steps of the processes
Many questions before to start
• Positive impacts ?• New risks ?• New risks ?• Return on investment ?• System selection ?• Commercial or homemade ?• Interoperability ?• User’s training strategy ?• User s training strategy ?• Acceptability ?
06/09/2013
12
Electronic systemsto catch errors
Industry stock
Prescription
CytosTPNDelivery
Pharmacy stock Ward stock Dispensation Production
EPR
TPNMP
( )
Delivery
Production stock
Raw-materialsanalysisProductionEnd-product
analysisAdministration
to patients
Electronic systemsto avoid errors
Industry stock
Prescription
CytosTPN
CPOE / CDSS
Pharmacy stock Ward stock Dispensation Production
EPR
TPNMP
EDI
CDSS
Production stock
Raw-materialsanalysisProductionEnd-product
analysisAdministration
to patients
06/09/2013
13
Robotisation of drug distributionSafety
François O et al, HUG, 2013
Selection 0%Conveyor 0.27%Manual finalisation 0%
≈ 4500 avoided errors/yr
Robotisation of drug distributionEfficiency
François O et al, HUG, 2013
- 2 FTEROI 4.5 years
06/09/2013
14
• Experimental
Automation of drug dispensingSafety
3
0
0.5
1
1.5
2
2.5
3
Erro
r rat
e [%
]
without
with
Du Pasquier C, Riberdy L, HUG, 2003
Automation of drug dispensingEfficiency
• Real life (digestive surgery ward)600
Min
utes
/wee
k
- 8h +4h +1h
200
300
400
500
600sans armoireau débuten routine
without
beginning
routine
M
François O et al, HUG, 2011
0
100
200
3AL Assistante PharmacienNurse Technician Pharmacist
06/09/2013
15
Administration to patientsBedside scanning
• Cytostatics DrugNurse
Physician
Database
Patient
Administration to patientsSafety
• Benefit of bedside scanning
• Wrong drug - 75%
• Wrong dose - 62%
• Wrong patient - 93%
• Wrong administration time - 87%
Gl b ll 80%Globally - 80%
Johnson, J Healthcare Inf Manag 2002;16:1
06/09/2013
16
Automated dispensing systemRobotized
distribution
The medication processFinal perspective
Clinicalinformation
system
EDI
Pharmacystock
Manufacturerstock
Wardstock
CPOE
Logisticinformation
systemBedside scanning Distribution
with scanning
Computer-assisted production management
• ObjectivesT t t f ti b IT – To support any type of preparation by IT
• Batches• Cytostatics• TPN• Other individualized prescriptions
– To implement in-process electronic controls duringthe most critical stepsthe most critical steps
– To link individualized preparation to theirprescription and their administration
06/09/2013
17
Production managementAutomation
Nutrition (Baxa)
Cytostatics(CytoCare)
CIVAS (Smartfiller)
PharmaHelp (Medical Dispensing Systems), Riva, …
Production managementGravimetry
• Cytostatics(Cato Cypro )
• Batch production(Cato, Cypro )
06/09/2013
18
Production management Efficiency
• Production – Parenteral nutrition (10/day)
- 60%
Manual2 x 3h = 6 h
Automated (BAXA)1 x 2.5h = 2.5 h
Prerequisite to successfulIT implementation
• Electronic management of processesElectronic management of processes(CPOE, stocks, …)
• Technical infrastructure (hard-, soft-)
• Actors identification (caregivers, patients, drugs)
• Acceptability (patients, caregivers)
• Adaptation to processes• Adaptation to processes• Project leadership• Financing
06/09/2013
19
Actors identificationThe patient
The caregiver The drug
Drug identification
Reconditionedby the pharmacy
Identified
?Identified
by the industry
06/09/2013
20
Drug identification
Unit dose• Hierarchy
Unit dose
Secondary package
Hospital package
Box
Pallet
= international standard
GS1 codification of pharmaceuticals at HUG
• Product ID (cytostatics)y
01 07613167000009 7003 1103161400 21 cyt-11198499GTIN - cytos EXP (date and time) Serial
06/09/2013
21
GS1 codification of pharmaceuticals at HUG
• Product ID (batch production)p
01 17613167001249 17 120831 10 PDS-11289663GTIN BatchEXP date
How to progress?
• Determine an institutional strategy and an implementation schedule taking into accountimplementation schedule, taking into account– the local organisation– the local culture– the expected return on investment
• Involve the different partners• Re-think the process organisation
(re-engineering)• Manage each projet independently, without
loosing the global vision
06/09/2013
22
Conclusion
• The medication process at the hospital iscomplex and involves many differentcomplex and involves many differentprofessionals
• A clever organisation contributes to improvethe safety, the efficiency, the communication and the traceability
• IT take more and more importance in the i h h iprocess improvement approaches: their
implementation is necessary but is a challenge• Each hospital must determine a strategy, based
on the local context
Questions ?
• On the presentation ?O h ?• On the use case ?